Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis.
Debashis HaldarAshnila JanmohamedTim PlantMatthew DavidsonHannah NormanEmily RussellOlivia SerevinaKenneth ChungKashif QamarBridget GunsonBettina HansenAlex RichterPalak J TrivediGideon M HirschfieldPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
In our single-centre cohort of patients with PBC, the presence of anti-gp210 was associated with an adverse presenting phenotype, predicted treatment non-response and independently predicted reduced transplant-free survival.